A new chance for SCID gene therapy

Nat Med. 1998 Jan;4(1):19-20. doi: 10.1038/nm0198-019.
No abstract available

Publication types

  • News
  • Comment

MeSH terms

  • Adenosine Deaminase / deficiency
  • Animals
  • Gene Transfer Techniques
  • Genetic Therapy / methods*
  • Hematopoietic Stem Cell Transplantation / methods
  • Humans
  • Janus Kinase 3
  • Lymphocyte Activation
  • Mice
  • Mice, SCID
  • Protein-Tyrosine Kinases / biosynthesis
  • Protein-Tyrosine Kinases / deficiency
  • Protein-Tyrosine Kinases / genetics*
  • Severe Combined Immunodeficiency / genetics
  • Severe Combined Immunodeficiency / immunology
  • Severe Combined Immunodeficiency / therapy*
  • T-Lymphocytes / immunology

Substances

  • Protein-Tyrosine Kinases
  • JAK3 protein, human
  • Jak3 protein, mouse
  • Janus Kinase 3
  • Adenosine Deaminase

Grants and funding